New cholesterol drug under Real-World watch in asia and latin america
NCT ID NCT07206472
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 26 times
Summary
This study tracks over 2,500 adults with high cholesterol who are taking bempedoic acid (alone or with ezetimibe) in routine medical care. Researchers want to see how safe the drug is and how it affects heart risk, especially in Asian and Latin American patients. No new treatment is given—just observation of what happens in normal doctor visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - InCor HCFMUSP
São Paulo, 05403-000, Brazil
Conditions
Explore the condition pages connected to this study.